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Abstract
The present study was performed to investigate the effects of valerian extract on the sleep-
wake cycle using sleep-disturbed model rats. A significant shortening in sleep latency was ob-
served with valerian extract at doses of 1000 and 3000 mg/kg. On the other hand, valerian extract
had no significant effects on total times of wakefulness, non-rapid eye movement (non-REM)
sleep, or REM sleep, even at a dose of 3000 mg/kg. Valerian extract at doses of 1000 and 3000
mg/kg showed a significant increase in the delta activity during non-REM sleep. In conclusion,
valerian extract may be useful as an herbal medicine having not only sleep-inducing effects but
also sleep quality-enhancement effects.
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The present study was performed to investigate the eﬀects of valerian extract on the sleep-wake cycle using sleep-disturbed model rats. A signiﬁcant shortening in sleep latency was observed with valerian extract at doses of 1000 and 3000 mg/kg. On the other hand, valerian extract had no signiﬁcant eﬀects on total times of wakefulness, non-rapid eye movement (non-REM) sleep, or REM sleep, even at a dose of 3000 mg/kg. Valerian extract at doses of 1000 and 3000 mg/kg showed a signiﬁcant increase in the delta activity during non-REM sleep. In conclusion, valerian extract may be useful as an herbal medicine having not only sleep-inducing eﬀects but also sleep quality-
enhancement eﬀects.
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V alerian, an herbal product consisting of the root of Valeriana oﬃcinalis, is used extensively as a traditional medicine for the treatment of insomnia and anxiety. For several decades, the use of valerian has decreased, and benzodiazepine sleep-inducers have taken the place of the herb［1］. However, it is well recognized that benzodiazepines have many unpleasant eﬀects, such as low tolerance by some users, dependence, rebound insomnia, amnesia, and muscle relaxation［2, 3］.
Therefore, particular attention should be given to the application of these hypnotics. In contrast, valerian showed no signiﬁcant adverse eﬀects, even at a dose approximately 20 times that of the recommended thera-
peutic dose［4］.
There have been some reports on the hypnotic eﬀects of valerian in humans［5-7］. In animal experiments,
Sakamoto et al.［8］reported that a 30  ethanol extract of valerian root signiﬁcantly prolonged hexobarbital-
induced sleep and decreased spontaneous ambulation and rearing with an open ﬁeld test in mice. Leuschner et al.
［9］also revealed that valerian root extract increased the thiopental sleeping-time in mice. However, there have been no reports that the eﬀects of valerian on the sleep-
wake cycle were studied in animals. In general, normal animals show a high-baseline sleep time during the day-
time, so the hypnotic eﬀect of valerian may be mild.
Given these reports, it seems likely that nobody has been able to observe a signiﬁcant eﬀect of valerian on the sleep-wake cycle in animals.
In a previous study, we developed a sleep-disturbed model that was useful for evaluating hypnotic potencies by placing rats on a grid suspended over water［10, 11］.
The hypnotic eﬀects of drugs in rats placed on the grid suspended over water were more potent than that in rats placed on sawdust. In the present study, therefore, we studied the eﬀect of valerian extract on the sleep-wake
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cycle using the sleep-disturbed model.
Materials and Methods
 
Wistar male rats weighing 230-310 g
(Japan SLC, Shizuoka, Japan)were used. All animals were maintained in an air-conditioned room with controlled temperature(24±2°C)and humidity(55±15
). They were housed in aluminium cages with sawdust and kept under a light-dark cycle(lights on from 7:00 to 19:00). The animals were allowed free access to food and water except during the experiments. All procedures involving animals were conducted in accordance with the guidelines of the Animal Care and Use Committee,
Faculty of Pharmaceutical Sciences, Okayama Univer-
sity.
The animals were anesthetized with pentobarbital sodium (Nembutal?, 35 mg/kg, i.p.,
Abbott Laboratories, North Chicago, IL, USA) and then ﬁxed in a stereotaxic apparatus (SR-5, Narishige,
Tokyo, Japan). For electroencephalogram (EEG)
recording, a stainless steel screw electrode was chroni-
cally implanted into the right frontal cortex(A:0.5, L:
3.0)according to the atlas of Paxinos and Watson［12］.
To record the electromyogram (EMG), we implanted stainless steel wire electrodes (200μm)into the dorsal neck muscle. A stainless steel screw ﬁxed in the left frontal bone served as a reference electrode. The elec-
trodes were connected to a miniature receptacle, and the whole assembly was ﬁxed to the skull with dental cement.
At least 7 days were allowed for recovery from the surgery.
EEG and EMG were recorded with an electroencephalograph (Model EEG 5113, Nihon Kohden, Tokyo, Japan)from 9:00 to 15:00. The recording was carried out according to the method described previously［11, 13］. The signals were ampliﬁed and ﬁltered(EEG, 0.5-30 Hz;EMG, 16-128 Hz), then digitized at a sampling rate of 128 Hz and recorded using the data acquisition program SleepSign ver.2.0(Kissei Comtec, Nagano, Japan). The EEG and EMG were measured in a plastic cage(30×18×24 cm)
that had a grid ﬂoor(29×15×7 cm). The cage was ﬁlled with water up to 1 cm below the grid surface. The stainless steel rods of the grid(3 mm wide)were set 2 cm apart from each other. The observation cage was placed in a sound-proof and electrically-shielded box(70×60×
60 cm).
The sleep-wake states were automatically classiﬁed by 10-sec epochs as wakefulness, non-rapid eye movement (non-REM), or REM sleep by SleepSign ver.2.0 according to the criteria previously described［10, 14］. As a ﬁnal step, the deﬁned sleep-wake stages were examined visually and corrected if necessary. Each state was characterized as follows:wakefulness, low-amplitude EEG and high-
voltage EMG activities;non-REM sleep, high-amplitude slow or spindle EEG and low-EMG activities;REM sleep, low-voltage EEG and EMG activities.
The delta activity during non-REM sleep was determined using a program of SleepSign ver.
2.0. The power spectrum densities, integrated and aver-
aged, could be divided into 4 frequency areas:delta wave
(0.5-4 Hz), theta wave(4-8 Hz), alpha wave(8-13 Hz),
and beta wave(13-30 Hz). The data of delta power in non-REM sleep were expressed as a percentage of the average delta activity in non-REM sleep during the entire recording period of each control group.
The valerian(Valeriana oﬃcinalis L.)root extract was provided by Kobayashi Pharmaceutical Co.,
Ltd. (Osaka, Japan). The root of Valeriana oﬃcinalis L.
was extracted with 70  ethanol at room temperature.
The extract was concentrated and spray-dried with 8 maltodextrin and 1  silicon dioxide. The drug was dissolved in water and administered orally at 9:00, and EEG and EMG were measured for 6 h after drug admin-
istration. Eight rats were used in each group, and a counterbalanced design for drug dosage was used. Drugs were administered at intervals of 7 days when the same rats were used for repeated experiments. Each rat was subjected to experimentation 4 times.
Values shown are means± S.E.M. Statistical analyses were performed using the software Dr. SPSS II (Nankodo Co., Ltd.,
Tokyo, Japan). One-way analysis of variance(ANOVA)
with Dunnett’s test was used for estimating the drug eﬀects. Sleep latency was deﬁned as the time from drug administration up until the ﬁrst 12 consecutive 10-s epochs of sleep.
Results
 
Valerian extract caused a dose-dependent decrease in sleep latency. A signiﬁcant shortening of sleep latency was observed at
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doses of 1000 and 3000 mg/kg (Fig. 1). On the other hand, valerian extract had no signiﬁcant eﬀects on the total times of wakefulness, non-REM sleep, or REM sleep, even at a dose of 3000 mg/kg (Fig. 2).
At 1-2 h after administration, rats given valer-
ian extract at a dose of 1000 mg/kg showed a signiﬁcant increase in delta activity during non-REM sleep. A signiﬁcant increase of delta power was also observed at 1
-2 and 2-3 h when a dose of 3000 mg/kg valerian extract
 
was given(Table 1).
Discussion
 
In the present study, we studied the eﬀect of valerian extract on sleep using a sleep-disturbed model developed by placing rats on a grid suspended over water. As described in the previous section, valerian extract caused a signiﬁcant shortening of sleep latency. Balderer and Borbe?ly［5］have reported that valerian extract at doses of 450 and 900 mg reduced sleep latency and awake time after sleep onset in healthy subjects. Francis and Demp-
ster［15］also reported that valerian treatment led to signiﬁcant reductions in sleep latency or nocturnal time awake and an increase in total sleep time compared to a placebo in children. This is the ﬁrst ﬁnding that valerian is an herbal product having hypnotic potency in rats with a sleep disturbance model.
To clarify whether valerian exerts an eﬀect on sleep quality, we studied the eﬀect of valerian on delta activities during non-REM, which are thought to reﬂect sleep quality. It is well known that delta power is an indicator of depth within non-REM sleep［16-18］. Valerian extract produced a signiﬁcant increase of delta activities during non-REM sleep. Schulz et al.［6］found that valerian induced an increase of slow wave sleep(SWS)in subjects with low amounts of SWS. Herrera-Arellano et al.［19］demonstrated that valerian extract increased delta sleep in patients suﬀering from insomnia. On the other hand, Vonderheid-Guth et al.［20］reported that in healthy volunteers, a valerian and hops extract combina-
tion produced a clear power increase in delta frequency at 2 and 4 h after administration. These ﬁndings revealed
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Fig.2  Eﬀects of valerian extract on total time of each sleep state in sleep-disturbed rats. Columns represent the means of each sleep state (n＝8). Drugs were administered orally, and EEG and EMG were measured for 6 h.
Fig. 1  Eﬀects of valerian extract on sleep latency in sleep-
disturbed rats. Columns and vertical bars represent means±S.E.M.
(n＝8). Drugs were administered orally. ?, ??, Signiﬁcantly diﬀerent from the control group at P＜0.05 and P＜0.01, respec-
tively.
Table 1  Eﬀects of valerian extract on delta activity during non-
REM sleep in sleep-disturbed rats
 
Hour  Control  
Valerian extract (mg/kg, p.o.)
300  1000  3000
 
0-1 h  92.7±6.6 104.5±9.4 108.1±8.9  107.3±8.0 1-2 h 109.0±2.1 117.1±6.3 129.6±6.5? 131.5±3.5??
2-3 h 103.6±3.2 110.2±2.6 111.2±6.7  122.8±5.4?
3-4 h  98.8±6.8 102.1±5.3 107.5±5.1  109.9±9.9 4-5 h  96.4±3.9  96.0±5.3 101.0±4.6  102.6±4.0 5-6 h  85.1±5.2  84.1±5.9  89.0±5.5  91.4±3.6(%)
Values represent means±S.E.M. (n＝8). Drugs were administered orally. ?, ??, Signiﬁcantly diﬀerent from control group at P＜0.05 and P＜0.01, respectively.
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that valerian extract enhances sleep quality.
The detailed mechanisms involved in the hypnotic eﬀects and the increasing of delta power during non-REM sleep induced by valerian are not yet clear. Santos et al.
［21, 22］reported that an aqueous extract of valerian inhibits (?H)γ-aminobutyric acid (GABA) uptake and induces the Ca?-independent release of (?H)-GABA.
Ortiz et al.［23］also reported that Valeriana oﬃcinalis extract increased both K?-and veratridine-stimulated(?H)
GABA release and caused the inhibition of(?H)GABA uptake. On the other hand, it is well known that GABA?
agonists, such as muscimol and 4, 5, 6, 7-
tetrahydroisoxazolo-(5, 4-c)pyridin-3-ol enhanced delta activity during non-REM sleep［17, 24］. From these ﬁndings, it seems likely that the extracellular GABA level increased by valerian extract caused the hypnotic eﬀects and the enhancement of delta activity during non-REM sleep through the GABA?receptor.
In conclusion, valerian extract may be useful as an herbal medicine having not only mild hypnotic eﬀects but also sleep quality-enhancement eﬀects.
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